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Abstract
The insulin/IGF-activated AKT signaling pathway plays a crucial role in regulating tissue growth and metabolism in
multicellular animals. Although core components of the pathway are well defined, less is known about mechanisms that
adjust the sensitivity of the pathway to extracellular stimuli. In humans, disturbance in insulin sensitivity leads to impaired
clearance of glucose from the blood stream, which is a hallmark of diabetes. Here we present the results of a genetic screen
in Drosophila designed to identify regulators of insulin sensitivity in vivo. Components of the MAPK/ERK pathway were
identified as modifiers of cellular insulin responsiveness. Insulin resistance was due to downregulation of insulin-like receptor
gene expression following persistent MAPK/ERK inhibition. The MAPK/ERK pathway acts via the ETS-1 transcription factor
Pointed. This mechanism permits physiological adjustment of insulin sensitivity and subsequent maintenance of circulating
glucose at appropriate levels.
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Introduction
The insulin signaling pathway is a highly conserved regulatory
network coordinating animal metabolism and growth with
nutritional status. In mammals, energy metabolism is regulated
by insulin, and tissue growth by insulin-like growth factors (IGFs),
through their respective receptors (for review see [1]). Drosophila
has a single insulin-like receptor protein (InR), which is activated
by a family of insulin-like peptides (ILPs) and mediates
physiological responses related to both metabolism and growth
(for review see [2]). InR stimulation leads to activation of the
phosphatidylinositol 3-kinase (PI3K)/AKT pathway. AKT is
recruited to the plasma membrane through phosphatidylinositol-
3,4,5-triphosphate (PIP3), which is generated by phosphorylation
of PI-4,5-P2 by PI3K (for review see [3]). Membrane-recruited
AKT is activated through phosphorylation by PDK1 and by TOR
complex 2 [4–6]. AKT has several downstream effectors,
including FOXO, a Forkhead transcription factor. AKT-mediated
phosphorylation promotes retention of FOXO in the cytoplasm,
thereby limiting FOXO activity [7]. AKT also promotes the
activity of TOR complex 1 by phosphorylating two of its upstream
regulators, TSC2 and PRAS40 [8–11].
Insulin signaling is involved in homeostatic regulation, gradually
adjusting physiological processes in response to variable nutritional
conditions. This tuning mode of regulation differs from many
developmental signaling pathways, which produce a limited range
of outputs (e.g. cell fate). Therefore, it is perhaps not surprising that
cellular insulin sensitivity is modulated byinput fromother signaling
pathways. For example, TORC1-regulated S6 kinase (S6K) inhibits
expression of the IRS scaffold proteins, which are recruited to
activated insulin/IGF receptors, thereby making cells more insulin
resistant [12,13]. Inflammatory signals, on the other hand, are
known to cause insulin resistance by c-Jun N-terminal kinase-
mediated phosphorylation of the IRS proteins (for review see [14]).
This is likely to contribute to the pathogenesis of type 2 diabetes.
While regulation of insulin sensitivity is clearly of physiological
importance, identifying novel regulatory mechanisms through
genetic screens has been challenging due to the need for a sensitive
readout that is also amenable to large-scale screening. The
Drosophila eye provides such a system. Because insulin signaling
limits FOXO activity, overexpression of FOXO can challenge the
regulatory capacity of the insulin pathway, creating a sensitized
genetic background [6,15]. Using this strategy to identify in vivo
modulators of insulin pathway activity, we have uncovered a novel
regulatory mechanism influencing insulin sensitivity. We show that
the extracellular signal-regulated kinase (ERK)/MAP kinase
signaling pathway (for review see [16]) influences cellular insulin
responsiveness controlling the expression of the insulin-like receptor
(inr) gene. This transcriptional regulation is mediated through the
Ets-1 orthologue, Pointed, a transcription factor regulated by the
MAPK/ERK pathway [17]. This mechanism provides a means
for integration of signaling input via the Epidermal growth factor
receptor (EGFR)-regulated MAPK/ERK with insulin-like signal-
ing to control systemic glucose homeostasis.
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MAPK/ERK pathway modulates insulin-induced cellular
responses
To identify novel modulators of insulin-like signaling we
screened for modifiers of FOXO overexpression, which produces
small rough eyes. This phenotype has earlier been shown to
respond to changes in insulin-like signaling in a highly sensitive
manner [6,15]. As insulin-like signaling is a known regulator of
growth, we focused on screening RNAi lines that had earlier
shown tissue undergrowth in a wing-based screen ([18], Figure S1).
Our screen identified the PI3K gene, which serves as a positive
control. The screen also identified kinase suppressor of ras (ksr)a sa n
enhancer of the FOXO gain-of-function phenotype. Downregu-
lation of ksr by RNAi enhanced the FOXO phenotype, but on its
own, did not reduce eye size (Figure 1A, quantified in Figure 1B).
The lack of an obvious eye phenotype resulting from ksr depletion
alone presumably reflects the magnitude of KSR downregulation
generated with the GMR-GAL4 driver during the phase of eye
imaginal disc growth. Enhancement of the FOXO overexpression
phenotype was also observed when one copy of the ksr gene was
removed (Figure S2). Removing one copy of the ksr gene on its
own did not reduce eye size, indicating the utility of the sensitized
background to identify subtle modulators of pathway activity.
FOXO is regulated at multiple levels, including nuclear
localization [7]. FOXO is nuclear in cells devoid of growth
factors, but upon insulin stimulation FOXO accumulates in the
cytoplasm through AKT-mediated phosphorylation ([7];
Figure 1C) As expected, RNAi-mediated depletion of PI3K
limited the insulin-induced shift toward cytoplasmic FOXO.
Depletion of KSR by RNAi produced a similar effect (Figure 1C;
representative images in Figure S3).
Does KSR act via AKT or does a parallel pathway override
AKT-mediated FOXO regulation? To address this, we monitored
insulin-induced activation of AKT. Depletion of KSR suppressed
insulin-induced phosphorylation of the activating ‘hydrophobic
motif’ site S505 on AKT (Figure 2A). The known functions of
Figure 1. KSR is involved in the regulation of FOXO activity. (A)
Photomicrographs of adult eyes. Upper panel: UAS-KSR
RNAi or UAS-FOXO
or both were expressed in the developing eye with the GMR-GAL4
driver. Lower panels: GMR-GAL4+UAS-FOXO also expressing UAS-RNAi
to deplete PI3K. (B) Quantification of the total area of affected eyes of
the indicated genotypes measured in pixels from digital images using
ImageJ. Error bars indicate standard deviation from measurement of at
least 6 eyes for each genotype. Student’s t-test: (***) p,0.001. (C)
Quantification of the subcellular localization of transfected FOXO-GFP.
S2 cells with GFP signal were classified into 3 groups according to FOXO
localization (N: predominantly nuclear; CN: equal levels in cytoplasm
and nucleus; C: predominantly cytoplasmic). Upper panels: compare
unstimulated cells with cells stimulated with insulin (10 mg/ml, 30 min).
Lower panels: Cells transfected with dsRNA to deplete PI3K or KSR and
after 4 days, stimulated with insulin. Error bars represent standard
deviation from 3 independent experiments. Fisher’s exact test was used
to assess the difference between insulin-stimulated S2 cells with and
without KSR depletion: (**) p,0.01; (***) p,0.001.
doi:10.1371/journal.pgen.1002429.g001
Author Summary
Insulin signaling is an important and conserved physio-
logical regulator of growth, metabolism, and longevity in
multicellular animals. Disturbance in insulin signaling is
common in human metabolic disorders. For example
insulin resistance is a hallmark of diabetes and metabolic
syndrome. While the core components of the insulin
signaling pathway have been well established, the
mechanisms that adjust the insulin responsiveness are
only known to a limited extent. Here we present results
from a genetic screen in Drosophila that was designed to
identify regulators of cellular insulin sensitivity in an in vivo
context. Surprisingly, we discovered cross-talk between
the epidermal growth factor receptor (EGFR)–activated
MAPK/ERK and insulin signaling pathways. This regulatory
mechanism, which involves transcriptional control of
insulin-like receptor gene, is utilized in vivo to maintain
circulating glucose at appropriate levels. We provide
evidence for a regulatory feed-forward mechanism that
allows for dynamic transient responsiveness as well as
more stable, long-lasting modulation of insulin respon-
siveness by growth factor receptor signaling. The combi-
nation of these mechanisms may contribute to robustness,
allowing metabolism to be appropriately responsive to
physiological inputs while mitigating the effects of
biological noise.
Insulin Sensitivity Regulated by MAPK/ERK
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changes in the canonical MAPK/ERK pathway would explain the
KSR effect on insulin signaling, we depleted D-MEK (MAP kinase
kinase). This produced an effect comparable to that of KSR
(Figure 2B). Insulin-induced AKT activation involves increase in
the level of plasma membrane phosphoinositide PIP3 through the
activity of PI3K [3]. To assess PIP3 levels, we used a GFP-linked
pleckstrin homology (PH) domain from GRP1 [21]. Insulin
treatment induced prominent membrane accumulation of the
GRP1-PH domain, which was prevented by depletion of PI3K
(Figure 2C). Similarly, RNAi-mediated depletion of KSR reduced
membrane localization of GRP1-PH in response to insulin.
To test whether other downstream targets of AKT besides
FOXO were affected by MAPK/ERK inhibition, we analyzed
phosphorylation of S6K, a target of TORC1 [22]. Insulin-induced
phosphorylation shifts some of the S6K protein into a ladder of
slower migrating forms [e.g. [23]], which was reduced by
depletion of KSR or D-MEK (Figure 2D). In both experiments
the effects were comparable to depletion of PI3K. To test, whether
MAPK/ERK signaling affected PI3K activity independent of
insulin, we overexpressed activated PI3K in the absence of insulin
stimulation and monitored AKT phosphorylation. In this setting,
knockdown of KSR had no influence on pathway activity (Figure
S4). In sum, these data suggest that reduced MAPK/ERK activity
lowers sensitivity to insulin stimulation, but does not hamper PI3K
from activating AKT.
MAPK/ERK regulates inr gene expression via the ETS-1
transcription factor Pointed
The data above suggested that MAPK signaling regulates the
insulin-like pathway above the level of PI3K. We therefore sought
to monitor InR expression level as well as activation making use of
a shift in its electrophoretic mobility caused by phosphorylation
(Figure 3A, lanes 1 and 4). Surprisingly, we found that depletion of
KSR led to a reduction in the total level of InR protein. This was
observed in both insulin-treated and untreated cells. Depletion of
PI3K did not produce a comparable effect. To confirm that InR
expression is regulated by the canonical MAPK/ERK pathway,
we silenced the expression of Raf and D-MEK, which also showed
reduced InR expression (Figure 3B). Increasing MAPK/ERK
pathway activity acts in the opposite direction: depletion of Gap1,
the GTPase activator of RAS, led to activation of MAPK/ERK
signaling visualized by phospho-specific antibody against the
active form of ERK (Figure 3C) as well as elevated InR expression
(Figure 3B). Thus, regulation of InR appears to be a specific
MAPK/ERK pathway effect and InR levels are sensitive to both
positive and negative changes in the MAPK/ERK activity.
How does MAPK/ERK signaling affect InR expression? Using
quantitative RT-PCR we observed a significant reduction in the
levels of the mature inr mRNA and the unspliced inr primary
transcript upon KSR depletion in S2 cells (Figure 3D). The
reduction in inr primary transcript levels upon KSR depletion
suggests that MAPK/ERK activity is likely to regulate inr
transcription. If so, we would expect transgene-directed expression
of inr to be refractory to the effects of MAPK pathway modulation.
This proved to be the case. A transfected version of inr under
control of a heterologous promoter was insensitive to KSR
depletion (Figure 4A). As an in vivo test we used GMR-Gal4 as a
heterologous promoter to direct expression of a UAS-InR transgene
in the eye. Under these conditions, KSR depletion did not
enhance the FOXO overexpression phenotype (Figure 4B, 4C).
The insensitivity of transgene-directed InR to the effects of KSR
depletion is consistent with the hypothesis of a mechanism
involving control of endogenous inr transcription.
pointed (pnt) encodesan ETS-1 transcriptionfactor that is activated
by MAPK/ERK through phosphorylationofa conservedthreonine
residue,T151 [24,25].We tested itsinvolvement intheregulationof
inr expression by depletion of Pointed from S2 cells by RNAi. This
caused a prominent reduction of inr mRNA (Figure 5A). To narrow
down the regulatory region of the inr gene we systematically
analyzed .20 kb upstream of the inr coding region by preparing a
series of luciferase reporter constructs (Figure S5), which lead to
identification of a minimal cis-regulatory region of 0.8 kB
(Figure 5B). Overexpression of Pointed-P2 in S2 cells increased
reporter activity directed by this 0.8 kB region (Figure 5C). This
fragment contained one site perfectly matching the consensus
Pointed binding site (59-(C/G)(A/C/G)GGA(A/T)(A/G)-39; [26]).
Mutating the consensus site reduced the ability of Pointed to induce
reporter expression (Figure 5C), suggesting binding to this site
contributes to Pointed-mediated regulation of inr gene expression.
Reciprocally, Pointed depletion in S2 cells led to a decrease in the
Figure 2. Impaired insulin signaling activation upon MAPK/ERK
inhibition. (A) Immunoblots to detect AKT phosphorylation. Cells were
treated with dsRNA to deplete KSR or PI3K and stimulated with insulin
(10 mg/ml, 30 min; ‘‘+’’) or left untreated (‘‘2’’). AKT phosphorylation
was detected by an antibody specific for the phosphorylated form of
the AKT ‘hydrophobic motif’ site S505. Antibody to total AKT protein
and Kinesin were used as loading controls. (B) Immunoblots to visualize
the level of AKT S505 phosphorylation and total AKT in cells treated
with dsRNA to deplete KSR, D-MEK or PI3K. Cells were stimulated with
insulin (30 min). Samples were run on the same gel, but intervening
lanes have been removed as indicated. (C) Visualization of the level of
PIP3 in the cell membrane by localization of a GFP-GRP1 PH domain
fusion protein. Left panel: photomicrographs showing translocation of
GFP-GRP1 PH to the membrane upon insulin stimulation. The ratio of
membrane to cytoplasmic GFP levels was measured as pixel intensity
along the white line. Right panel: histogram showing the ratio of
membrane to cytoplasmic GFP levels. PI3K and KSR depleted cells
showed less PH domain membrane localization upon insulin stimula-
tion. Student’s t-test: (***) p,0.001. (D) Immunoblots to visualize the
level of S6K phosphorylation in cells treated with dsRNA to deplete KSR,
PI3K or D-MEK. Cells were stimulated with insulin (10 mg/ml, 30 min).
The slower migrating forms correspond to phosphorylated S6K. Left
panel: samples were run on the same gel, but intervening lanes have
been removed as indicated.
doi:10.1371/journal.pgen.1002429.g002
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induced AKT S505 phosphorylation (Figure 5E).
To further test this relationship in vivo, we asked whether
reducing pointed levels would influence the severity of the FOXO
overexpression phenotype. Removing one copy of the pointed gene
using three independent alleles modestly but significantly en-
hanced the FOXO overexpression phenotype in the eye
(Figure 5F, Figure S6). These findings suggest that the MAPK/
ERK pathway acts via the Ets-1 transcription factor Pointed to
control cellular insulin sensitivity.
MAPK/ERK regulates inr gene expression to control
glucose metabolism
To begin to explore the physiological role of regulation of InR
levels by the MAPK/ERK pathway in vivo, we performed a survey
of larval tissues and found that KSR depletion led to significant
reduction of inr transcript levels in imaginal discs and larval fat
body, Drosophila equivalent of liver and adipose tissue (Figure 6A).
KSR depletion also led to a reduction of InR protein levels
(Figure 6B) as well as nuclear FOXO accumulation in the larval fat
body (Figure 6C). MAPK/ERK signaling can be regulated by a
variety of receptor tyrosine kinases (RTKs). We next made use of
pumpless-GAL4 to manipulate RTK activity. Pumpless is active
mainly in the fat body, but also other tissues, such as parts of larval
gut. Inhibition of Epidermal growth factor (EGF) signaling by
expression of a dominant negative form of EGFR (dnEGFR) led to
downregulation of inr mRNA (Figure 6D) and protein levels
Figure 4. InR transgene expressed under heterologous pro-
moter is insensitive to KSR depletion. (A) Immunoblots to visualize
the level of Flag-tagged InR protein expressed under control of the pMT
promoter in transfected S2 cells. Cells were treated with dsRNA to
deplete PI3K, KSR or GFP as a control and after 5 days stimulated with
insulin. Insulin activity was visualized using antibody specific to the
phosphorylated form of InR (upper panel). Total Flag-InR was visualized
with anti-Flag. Anti-Kinesin was used as loading control. Samples were
run on the same gel, but intervening lanes have been removed as
indicated. (B) Adult eyes expressing GMR-Gal4 and UAS-FOXO, UAS-InR
and/or a UAS-ksr
RNAi transgene to deplete KSR. (C) Quantification of the
total eye area measured in pixels from digital images using ImageJ.
Error bars indicate standard deviation from measurement of at least 5
eyes for each genotype. Student’s t-test: (***) p,0.001. (N.S.) indicates
that there was no significant effect of KSR depletion in the UAS-
FOXO+UAS-InR eyes.
doi:10.1371/journal.pgen.1002429.g004
Figure 3. MAPK/ERK signaling regulates inr gene expression.
(A) Immunoblot to visualize the level of InR protein. Cells were treated
with dsRNA to deplete PI3K, KSR or GFP as a control and after 5 days
stimulated with insulin. In control cells, insulin stimulation results in a
phosphorylation-induced mobility shift in SDS-PAGE. Anti-Kinesin was
used as loading control. (B) Immunoblots to visualize the level of InR
protein in cells treated with dsRNA to deplete Raf, D-MEK or GAP1.
Samples were run on the same gel, but intervening lanes have been
removed as indicated. (C) Immunoblot to visualize the MAPK/ERK
activity using an antibody specific to the phosphorylated form of ERK.
S2 cells were treated with dsRNA to deplete GAP1 or left untreated.
Anti-Kinesin was used as a loading control. Samples were run on the
same gel, but intervening lanes have been removed as indicated. (D)
Histogram showing the levels of rp49, inr and ksr mRNAs measured by
quantitative RT-PCR. S2 cells were treated with dsRNA to deplete ksr
(gray bars) or left untreated (white bars). Total RNA were extracted and
normalized for cDNA synthesis. RNA levels were normalized to kinesin
mRNA. The efficiency of ksr depletion was ,60%. inr denotes the
mature mRNA; pri-inr denotes the unspliced nuclear primary transcript
measured using intron-specific primers. Error bars represent standard
deviation from 3 independent experiments. Student’s t-test: (*) p,0.05.
doi:10.1371/journal.pgen.1002429.g003
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physiologically relevant upstream regulator of MAPK/ERK-
mediated control in Inr expression in vivo.
Systemic regulation of InR activity has been shown to influence
metabolic homeostasis [reviewed in [27]]. In this context, the
effects of KSR depletion on inr expression and FOXO localization
in fat body were suggestive of a link to energy metabolism. To ask
whether reduction of inr to half of normal levels was sufficient to
cause a metabolic disturbance, we made use of larvae carrying one
copy of the deletion Df(3R)BSC678, which fully removes the inr
gene (Figure 5B). Quantitative RT-PCR was used to confirm that
inr mRNA levels were reduced to ,50% in these animals
(Figure 7A). Notably, this result indicates that there is little or no
feedback from InR signaling on inr expression, and suggests that
there is limited output from InR via the MAPK pathway in
Drosophila. In addition, we observed that flies with modestly
reduced inr levels showed impaired capacity to limit FOXO
activity in the eye (Figure S7).
Larvae lacking one copy of the inr gene showed no significant
change in levels of stored glycogen and triglycerides or trehalose
(Figure S8), a circulating disaccharide synthesized by the fat body
through glycogenolysis ([28]). However, levels of circulating
glucose in the hemolymph were substantially increased
(Figure 7B), suggesting compromised clearance of dietary glucose
from the circulation. To ask whether this phenotype could be
achieved by independent genetic means, we used pumpless-GAL4 to
drive expression of a UAS-inr
RNAi transgene to deplete InR
(Figure 7C). These animals showed elevated glucose in their
hemolymph, verifying that regulation of InR levels is physiolog-
ically important in vivo in maintaining levels of circulating glucose.
This conclusion was further supported by the finding that InR
overexpression modestly, but significantly, decreased levels of
circulating glucose (Figure S9). These findings are consistent with
what has been reported in flies in which the ability to produce
insulin-like peptides was compromised by genetic ablation of the
insulin-producing neurosecretory cells [29]. These flies showed a
Figure 5. inr is regulated by the ETS-1 transcription factor Pointed. (A) Measurement of inr transcript levels in S2 cells transfected with dsRNA
to deplete pointed mRNA or left untreated. The efficiency of pointed depletion was ,70%. inr was reduced to ,50% compared to rp49 after
normalization to kinesin mRNA. Error bars represent standard deviation based on 4 independent experiments. Student’s t-test: (*) p,0.05. (B)
Schematic representation of the inr locus. Thick black arrow lines indicate transcripts of inr and E2F. The cis-regulatory region identified by luciferase
assay is shown in red and the Pnt consensus site sequence is indicated. Thick gray lines represent deletions used in Figure 7 as well as Figures S7 and
S8. Note that the deletions affect multiple genes. Only inr and adjacent E2F loci are indicated. (C) Luciferase assays showing activation of the reporter
plasmids after cotransfection with a vector to express Pnt-P2 (gray bars) or empty vector as a control (white bars). pro-inr denotes luciferase reporter
with the DNA element from the inr cis control region shown in (B). mut denotes luciferase reporter with the Pnt consensus site mutated. pGL3-Basic
was used as the control reporter. Error bars represent standard deviation based on 4 independent experiments. Student’s t-test: (***) p,0.001. (D)
Immunoblot to visualize the level of InR protein in S2 cells treated with dsRNA to deplete pointed or left untreated. Anti-Kinesin was used as a loading
control. (E) Immunoblot to visualize the level of AKT S505 phosphorylation in S2 cells treated with dsRNA to deplete pointed. After 5 days cells were
stimulated with insulin (30 min). (F) Upper panel: Photographs of adult eyes. From left to right: GMR-Gal4 alone; GMR-Gal4 with one mutant copy of
the pointed gene (pnt
D88 allele); GMR-Gal4+UAS-FOXO; GMR-Gal4+UAS-FOXO with one mutant copy of the pointed gene (pnt
D88 allele). Lower panel:
Plot of total eye area measured in pixels from digital images using ImageJ. Error bars indicate standard deviation from measurement of at least 5 eyes
for each genotype. Student’s t-test: (***) p,0.001.
doi:10.1371/journal.pgen.1002429.g005
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levels [29]. Similarly, insulin signaling in mammals regulates
glucose uptake and reduced insulin sensitivity is linked to
hyperglycemia, metabolic syndrome and type-2 diabetes [30,31].
To test whether MAPK/ERK-regulation of InR expression is
involved in maintaining systemic glucose homeostasis, we assessed
the effects of KSR RNAi. Depletion of KSR led to elevated levels
of circulating glucose (Figure 7D). If the effect of KSR depletion is
due to reduced InR levels, we would expect restoring inr
expression under Gal4 control to lower glucose levels toward
normal. This proved to be the case (Figure 7D). As expected,
expression of a dnEGFR using pumpless-GAL4 driver also resulted
in elevated circulating glucose (Figure 7E). The glucose levels were
restored by simultaneous overexpression of Pointed, which is in
agreement with the view that Pointed acts as a downstream
effector of the pathway (Figure 7F). These observations suggest a
physiological role for EGFR-MAPK/ERK-Pointed activity in
control of glucose homeostasis via regulation of InR levels.
The insulin signal transduction pathway is regulated by cross-
talk from several other signaling pathways. This includes input
from the amino-acid sensing TOR pathway into regulation of
insulin pathway activity by way of S6 kinase regulating IRS [12–
14]. Signaling downstream of growth factor receptors has also
been linked to regulation of insulin signaling [32,33]. The active
form of the small GTPase Ras can bind to the catalytic subunit of
PI3K and promote its activity. Expression of a form of PI3K that
cannot bind Ras allows insulin signaling, but at reduced levels
[33]. The work reported here provides evidence for a second
mechanism through which growth factor receptor signaling
through the MAPK/ERK pathway modulates insulin pathway
activity. Transcriptional control of inr gene expression by EGFR
signaling may provide a means to link developmental signaling to
regulation of metabolism. In this context, we noted a statistically
significant correlation between EGFR target gene sprouty and inr
gene expression at different stages during Drosophila development
(Figure S10).
Several steps of the insulin pathway can be regulated by
phosphorylation. Given that the MAPK/ERK pathway is a kinase
cascade, a priori, the possibility of phosphorylation-based
interaction between these pathways would seem likely. However,
this appears not to be the case. Acute pharmacological inhibition
of the MAPK/ERK pathway proved to have no impact on insulin
pathway activity (Figure S11). Thus short-term changes in
MAPK/ERK pathway activity do not seem to be used for
transient modulation of insulin pathway activity. Instead, the
MAPK/ERK pathway acts through the ETS-1 type transcription
factor Pointed to control expression of the inr gene. Transcrip-
tional control of inr suggests a slower, less labile influence of the
MAPK pathway. Taken together with the earlier studies [32,33],
our findings suggest that growth factor signaling can regulate
insulin sensitivity by both transient and long-lasting mechanisms.
Why use both short-term and long-term mechanisms to
modulate insulin responsiveness to growth factor signaling? The
use of direct and indirect mechanisms that elicit a similar outcome
is reminiscent of feed-forward network motifs [34]. Although these
motifs are often thought of in the context of transcriptional
Figure 6. EGFR-MAPK/ERK signaling regulates InR expression and FOXO localization in vivo. (A) Histogram showing the levels of rp49, inr
and ksr mRNAs measured by quantitative RT-PCR. Wandering 3
rd instar larvae expressed UAS-ksr
RNAi under ubiquitous tubulin-Gal4 control. Controls
expressed tubulin-Gal4 without the UAS-RNAi transgene. Total RNA was isolated from imaginal discs, fat body, salivary gland and body wall. RNA
levels were normalized for cDNA synthesis before Q-PCR. RNA levels were normalized to kinesin mRNA. The efficiency of KSR depletion is shown in
dark gray bars. Student’s t-test: (*) p,0.05. (B) Immunoblot to detect the level of InR protein in fat body from wandering 3
rd instar larvae expressed
UAS-KSR
RNAi under Tubulin-Gal4 control. Samples were run on the same gel, but intervening lanes have been removed as indicated. (C) Left panels:
Immunofluorescent images of fat body dissected from wandering 3
rd instar larvae stained with anti-FOXO (green). Nuclei were labeled with DAPI
(Blue). Larvae expressed UAS-ksr
RNAi under pumpless-Gal4 control. Control larvae expressed Gal4 without the RNAi transgene. Right panel:
Quantification of the ratio between nuclear FOXO and cytoplasmic FOXO in fat body expressing ppl-Gal4 or with UAS-ksr
RNAi. Subcellular regions were
defined by DAPI staining. FOXO intensities were measured in pixels from digital images using ImageJ. Error bars represent standard deviation from
measurement of at least 24 cells for each genotype. Student’s t-test: (***) p,0.001. (D) Histogram showing the levels of rp49 and inr mRNAs
measured by quantitative RT-PCR. Wandering 3
rd instar larvae expressed UAS-dnEGFR under pumpless-Gal4 control. Controls expressed Gal4 without
the UAS transgene. Total RNA was isolated from the fat body. RNA levels were normalized to kinesin mRNA. Error bars represent standard deviation
from 3 independent experiments. Student’s t-test: (*) p,0.05. (E) Immunoblot to visualize the level of InR protein in fat body from wandering 3
rd
instar larvae expressing UAS-dnEGFR under pumpless-Gal4 control. Samples were run on the same gel, but intervening lanes have been removed as
indicated.
doi:10.1371/journal.pgen.1002429.g006
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context of more complex systems involving signal transduction
pathways. In multicellular organisms, feed-forward motifs are
often used to make cell fate decisions robust to environmental
noise [35]. Our findings suggest a scenario in which a feed-forward
motif is used in the context of metabolic control, linking growth
factor signaling to insulin responsiveness. In this scenario, growth
factor signaling acts directly via RAS to control PI3K activity and
indirectly via transcription of the inr gene to elicit a common
outcome – sensitization of the cell to insulin. This arrangement
allows for a rapid onset of enhanced insulin sensitization, followed
by a more stable long-lasting change in responsiveness. Thus a
transient signal can both allow for an immediate as well as a
sustained response. The transcriptional response also makes the
system stable to transient decreases in steady-state growth factor
activity. We speculate that this combination of sensitivity and
stability allows responsiveness while mitigating the effects of noise
resulting from the intrinsically labile nature of RTK signaling. As
illustrated by our data, failure of this regulation in the fat body
leads to elevated circulating glucose levels, likely reflecting
impaired clearance of dietary glucose from the circulation by the
fat body. Maintaining circulating free glucose levels low is likely to
be important due to the toxic effects of glucose [28]. In contrast,
circulating trehalose, glycogen or triglyceride levels showed no
significant change in animals with reduced InR expression,
suggesting that these aspects of energy metabolism can be
maintained through compensatory mechanisms in conditions of
moderately impaired insulin signaling.
Earlier studies by Puig and coworkers have shown that the
transcription of the inr gene is under dynamic control [36,37].
Activation of FOXO in the context of low insulin signaling leads to
upregulation of inr transcription, thus constituting a feedback
regulatory loop. Thus, InR expression appears to be under control
of two receptor-activated cues, which have opposing activities: inr
expression is positively regulated by the EGFR-MAPK/ERK
module, but negatively regulated by its own activity on FOXO. In
the setting of this study, the cross-regulatory input from the
MAPK/ERK pathway was found to dominate over the autoreg-
ulatory FOXO-dependent mechanism. If conditions exist in which
the FOXO-dependent mechanism was dominant, we would
expect to observe a limited potential for crossregulation by the
MAPK/ERK pathway. Whether Pointed and FOXO display
regulatory cooperativity at the inr promoter is an intriguing
question for future study.
Materials and Methods
Fly strains
UAS-InR, pnt
D88, pnt
07825, UAS-Pnt-P2, ksr
S-627, Df(3R)Exel6186,
Df(3R)ED6076 and Df(3R)BSC678 flies were obtained from the
Bloomington Stock Center. UAS-RNAi-PI3K, UAS-RNAi-KSR and
UAS-RNAi-InR lines were from the Vienna Drosophila RNAi center.
pUAST-FOXO-GFP flies were provided by Aurelio Teleman.
pUAST-dnEGFR flies were provided by Pernille Rørth. pnt
T5 flies
were provided by Christian Kla ¨mbt.
Cell culture and treatments
S2 cells were grown at 25uC in SFM (Gibco) supplemented with
L-glutamine. dsRNA was prepared using MegascriptT7 (Ambion)
with the following templates: PI3K, nucleotides 358–857 of
Pi3K92E coding sequence (FBpp0083348); ksr, nt 2224–2710
(FBpp0078413); D-MEK, nt 961–1191 of the ORF plus the first
83 nt of the 39UTR (FBtr0071313); Raf, nt 522–912
(FBpp0110324);GAP1, nt 153–646 (FBpp0076096); pnt, nt 1541–
1957 (718AA isoform, FBpp0088658); GFP, nt 17–633 of EGFP2,
was used as control. S2 cells were treated with 37 nM dsRNA.
Cells were transfected using effectene reagent (QIAGEN) with
pMT-GAL4, pUAST-FOXO-GFP or pUAST-Myc-Dp110CAAX,o r
pMT-GFP-PH or pMT-InR-Flag or pMT-Pnt-P2. 0.7 mM CuSO4
was used to induce FOXO, Dp110, GFP-PH, InR or Pnt
expression after transfection. The following primers were used to
clone InR-Flag into pMT vector with EcoRI, NotI and XhoI sites
by fusion: 59-GGTACCTACTAGTCCAGTGTGGTGGAATT-
CATGTTCAATATGCCACGGGGAGTGAC-39;5 9- TTCGA-
AGGGCCCTCTAGACTCGAGCGGCCGCTTACTTGTCA-
TCGTCGTCCTTGTAGTCCGCCTCCCTTCCGATGAATC-
CA-39;5 9- ACGTTGCGCTCGAGCCAGAGCTCGA-39 and
59- TCGAGCTCTGGCTCGAGCGCAACGT-39. The primers
used to clone pntp2 into pMT-Myc by SLIC at EcoRI site were:
forward, 59-AGTGCAACTAAAGGGGAATTCATGGAATTG-
GCGATTTGTAAAACAG-39; reverse, 59- GATAAGCTTCT-
Figure 7. MAPK/ERK regulates inr e x p r e s s i o nt oc o n t r o l
circulating glucose levels. (A) Histogram showing the levels of
rp49, inr mRNAs and inr primary transcript (pri-inr) measured by
quantitative RT-PCR in control (y
2,w
2) and Df(3R)BSC678/+ larvae. Error
bars represent standard deviation from 3 independent experiments. (B)
Histogram showing glucose levels in control (y
2,w
2) and Df(3R)BSC678/
+ larval hemolymph. Error bars represent standard deviation from 3
independent experiments. Student’s t-test: (**) p,0.01. (C) Histogram
showing glucose levels in hemolymph from larvae expressing UAS-
InR
RNAi under pumpless-Gal4 control. Error bars represent standard
deviation from 3 independent experiments. Student’s t-test: (*) p,0.05.
(D) Histogram showing the levels of circulating glucose in hemolymph.
Wandering 3
rd instar larvae expressed UAS-KSR
RNAi under Tubulin-Gal4
with or without co-expressed UAS-inr. Controls expressed Gal4 without
the RNAi transgenes. Student’s t-test: (**) p,0.01. (E) Histogram
showing glucose levels in hemolymph from larvae expressing UAS-
dnEGFR under pumpless-Gal4 control. Error bars represent standard
deviation from 3 independent experiments. Student’s t-test: (*) p,0.05.
(F) Histogram showing the levels of circulating glucose from larvae
expressing UAS-dnEGFR without or with overexpression of Pointed
under pumpless-Gal4 control. Error bars represent standard deviation
from 3 independent experiments. Student’s t-test: (*) p,0.05.
doi:10.1371/journal.pgen.1002429.g007
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39. The primers used to clone the inr gene regulatory region into
pGL3-Basic at HindIII and XhoI sites were: forward, 59-
GCGTGCTAGCCCGGGCTCGAGTGAGAGTTTCATGTG-
TCAGA -39; reverse, 59- AAGCTTACTTAGATCGCAGA-
TGTTAATTGCACAGCAAGCTC-39. The primers used to
mutate the predicted Pnt consensus site with QuickChange II
XL kit were: forward, 59-GAGAATGCCGGAGATGAAGAC-
GCGAACGAAGATGAAGTCGATG-39; reverse, 59- CATC-
GACTTCATCTTCGTTCGCGTCTTCATCTCCGGCATT-
CTC-39.
Cell imaging
For FOXO-GFP localization, live S2 cells were imaged using a
Leica SP5 confocal microscope. Images were taken of random
fields within 15 min after 10 mg/ml insulin boost for 30 min and
scored for GFP localization (scoring was done ‘blind’). For GFP-
PH images were taken within 10 min after 10 mg/ml insulin boost
for 5 min. The ratio of membrane to cytoplasmic GFP levels was
measured as pixel intensity along the white line as indicated in
Figure 2C (left panel). For fat body FOXO immunofluorescent
staining, newly hatched 1
st instar larvae were seeded at 50/vial
and reared at 25uC. Wandering 3
rd instar larvae were dissected.
Tissues were fixed in PBS with 4% paraformaldehyde at room
temperature for 20 min. Anti-FOXO antibody [36] was used at
1:1000 dilution. Fat body connected with salivary gland was
imaged using a Zeiss LSM700 confocal microscope.
Immunoblotting
Cells were homogenized in SDS sample buffer, boiled and
resolved by SDS-PAGE before transfer to nitrocellulose mem-
branes for antibody labeling. Antibodies to phospho-S505-AKT,
AKT, P-InR and Myc were from Cell Signaling Technology.
Anti-Kinesin was from Cytoskeleton. Phospho-ERK antibody was
from Sigma. Anti-S6K is described in [38]. Anti-dInR is described
in [37].
Quantitative RT–PCR
Total RNA was extracted from S2 cells using QIAGEN RNeasy
Mini Kit and treated with On-Column DNase (QIAGEN RNase-
Free DNase Set) at room temperature for 15 min to eliminate
genomic DNA contamination. Reverse transcription to synthesize
the first strand used oligo-dT primers and Superscript RT-III
(Invitrogen). PCR was performed using POWER SYBR GREEN
Master Mix (Applied Biosystems) and analyzed on Applied
Biosystems 7500 fast real-time PCR system. Results were
normalized to Kinesin mRNA, and rp49 was used as a control.
The following primers were used: Kinesin-f, 59-GCTGGAC-
TTCGGTCGTAGAG-39; Kinesin-r, 59- CTTTTCATAGCG-
TCGCTTCC-39; rp49-f, 59- GCTAAGCTGTCGCACAAA-39;
rp49-r, 59- TCCGGTGGGCAGCATGTG-39; InR-f, 59- CTG-
GTGGTGCTGACAGAGAA-39; InR-r, 59- GCAGCTGACA-
ACTGGCATTA-39; pri-InR-f, 59- CAAGAGACAGCAACA-
AAAGG-39; pri-InR-r, 59- GCTTGCATGTGTTGGTGAGC-
39; KSR-f, 59- AGCCGAGCGAAGATTGTAAA-39; KSR-r, 59-
TCCCGATACATGCCTACACA-39; pnt-f, 59- CGATGCGAA-
TGCCTACTACACG-39; pnt-r, 59- TGCTGGTGTTGTAGC-
CTGAAC-39.
Metabolic analysis
Newly hatched 1
st instar larvae were seeded at 50/vial and
reared at 25uC. Hemolymph was extracted from wandering stage
3
rd instar larvae. 2 ml of pooled hemolymph was diluted with 8 ml
Tris buffered saline (pH 6.6) and incubated at 70uC for 5 min
before clarification by centrifugation at 20 0006g for 1 min.
Glucose was measured in 6 ml supernatant using the GAGO-20 kit
(Sigma) and normalized to the same amount of TBS as blank
control. For trehalose measurement, supernatant was incubated
with 7.5 mg trehalase (Sigma) overnight at 37uC and measured
using GAGO-20 kit as well. For glycogen and triglyceride
measurements, 3
rd instar larvae were homogenized using Sartorius
Potter-S tissue homogenizer in water with 0.05% Tween.
Supernatant was collected after 5 min of heat inactivation at
70uC and centrifugation at 13000 rpm for 3 min. Glycogen and
protein levels were measured using Glycogen assay kit (Bio Vision)
and Bio-Rad protein assay reagent, respectively. Triglyceride was
measured using Sigma Triglyceride kit. Data were normalized to
total protein.
Supporting Information
Figure S1 Effect of depleting KSR, AKT or Raf on growth in
the wing. UAS RNAi transgenes targeting AKT, KSR or Raf were
expressed in the posterior compartment of the wing imaginal discs
under control of engrailed-Gal4. Knockdown of MAPK/ERK
pathway components lead to undergrowth similar to that caused
by suppression of insulin signaling pathway. Upper panels: show
photographs of the resulting adult wings. Red dots indicate the
border between anterior and posterior compartments. Note the
reduced area of the P compartment. Lower panels: higher
magnification views showing individual cell size (each cell
produces a single hair, so cell size can be inferred from the
spacing of the hairs).
(TIF)
Figure S2 Effect of reduced ksr gene dosage on the FOXO
overexpression phenotype. Upper panel: Photographs of adult
eyes. From left to right: GMR-Gal4 alone; GMR-Gal4 with one
mutant copy of the ksr gene; GMR-Gal4+UAS-FOXO; GMR-
Gal4+UAS-FOXO with one mutant copy of the ksr gene. Lower
panel: Plot of total eye area measured in pixels from digital images
using Image J. Error bars indicate standard deviation from
measurement of at least 5 eyes for each genotype. (*) Student’s t-
test for removing one copy of ksr in GMR-Gal4+UAS-FOXO eyes
p,0.05.
(TIF)
Figure S3 Representative images showing FOXO localization in
S2 cells. Subcellular localization of FOXO-GFP in S2 cells
visualized by confocal microscopy. Left panel: (N) predominantly
nuclear. Middle panel: (CN) equal levels in cytoplasm and nucleus.
Right panel: (C) predominantly cytoplasmic.
(TIF)
Figure S4 KSR acts upstream of PI3K. Immunoblots to
visualize the level of AKT and ERK phosphorylation in S2 cells
transfected to express the membrane-tethered form of Dp110
(CAAX) compared to control cells transfected with the empty
vector. Cells were cultured in serum-free medium and were not
stimulated by addition of insulin. Upper to lower: antibody to
phosphorylated S505 AKT; antibody to total AKT; Antibody to
the phosphorylated form of ERK; antibody to the Myc epitope tag
to visualize expression of the Dp110 transgene. Samples were run
on the same gel, but intervening lanes have been removed as
indicated.
(TIF)
Figure S5 Schematic representation of the fragments used to
locate the inr cis-regulatory region. Thick black arrow lines indicate
transcripts of inr. The five putative cis-regulatory regions analyzed
Insulin Sensitivity Regulated by MAPK/ERK
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line indicates the active region, which was used to narrow down to
the 0.8 kb element in Figure 5B. Note that only inr gene is
indicated.
(TIF)
Figure S6 Independent pointed alleles modestly but significantly
enhanced the FOXO overexpression phenotype in the eye. (A)
Adult eyes expressing GMR-Gal4 and UAS-FOXO without or with
one mutant copy of the pointed gene (pnt
07825 or pnt
T5 as indicated).
(B) Plot of total eye area measured in pixels from digital images
using ImageJ. Error bars indicate standard deviation from
measurement of 7 eyes for each genotype. Student’s t-test: (***)
p,0.001.
(TIF)
Figure S7 Genetic tests of reduced inr function in vivo. (A,B)
Adult eyes expressing GMR-Gal4 alone or with UAS-FOXO. Exe/+
indicates flies with one copy of the deletion Df(3R)Exel6186 that
partially removes inr locus. The total area of eyes was measured in
pixels from digital images using ImageJ. Error bars indicate
standard deviation from measurement of at least 5 eyes for each
genotype. Student’s t-test: (***) p,0.001. (C) Histogram showing
the level of inr mRNA measured by quantitative RT-PCR in
control and Df(3R)Exel6186/+ flies. (D) Control deletion
Df(3R)ED6076 does not sensitize to FOXO overexpression. Adult
eyes expressing GMR-Gal4 alone or with UAS-FOXO. +/+
indicates 2 intact copies of the inr locus. Df(3R)ED6076/+
indicates the flies with one copy of the deletion, which is otherwise
similar to Df(3R)Exel6186, but does not affect inr. Histograms
showing quantification of eye size of the indicated genotypes are
shown at right. Error bars indicate standard deviation from
measurement of at least 5 eyes for each genotype. See Figure 5B
for schematic representation of the deletions used to disrupt inr
function.
(TIF)
Figure S8 No change in levels of stored glycogen and
triglycerides or circulating trehalose. Histograms showing glycogen
(left) and triglyceride (right) levels normalized to total protein in
control (+/+) and Df(3R)BSC678/+ larvae. Error bars represent
standard deviation from 3 independent experiments. Lower panel:
Histogram showing trehalose levels in hemolymph from wander-
ing 3
rd instar control (+/+) and Df(3R)BSC678/+ larvae.
(TIF)
Figure S9 InR overexpression modestly, but significantly,
decreased levels of circulating glucose. Wandering 3
rd instar
larvae expressed UAS-inr under Tubulin-Gal4 control. Error bars
represent standard deviation from at least 3 independent
experiments. Student’s t-test: (*) p,0.05.
(TIF)
Figure S10 Correlation between the levels of inr and EGFR
target sty mRNAs at various stages of Drosophila development.
RNA levels were determined using RNA-seq data from mod-
ENCODE (www.modencode.org) by cufflinks (cufflinks.cbcb.um-
d.edu). Spearman’s correlation coefficient rho=0.71 (P,0.001).
E# indicates hours of embryonic development. L# indicates
larval stage. P# indicates days of pupal development. ad5d
indicates 5 day adult.
(TIF)
Figure S11 Acute pharmacological inhibition of MAPK/ERK
has no impact on insulin activity. Immunoblots to visualize the
level of AKT and ERK phosphorylation in S2 cells treated with
the MEK inhibitor U0126 (Promega) or in control cells. Cells were
treated with dsRNA to deplete PI3K, KSR or GFP as a control
and after 5 days stimulated with insulin and treated with 10 mM
U0126 for 10 min as indicated. Pharmacological inhibition of
MEK by U0126 was effective, as visualized by anti-P-ERK. Anti-
Kinesin was used as loading control. Samples were run on the
same gel, but intervening lanes have been removed as indicated.
(TIF)
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